Fats and bile salts. II. Pathologic considerations.
D001646:Bile / Q000378:metabolism*; D001647:Bile Acids and Salts / Q000378:metabolism / Q000502:physiology; D055598:Chemical Phenomena; D002621:Chemistry; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003424:Crohn Disease / Q000503:physiopathology; D004035:Diet Therapy; D004041:Dietary Fats / Q000378:metabolism / Q000627:therapeutic use; D005227:Fatty Acids / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D007410:Intestinal Diseases / Q000503:physiopathology; D007421:Intestine, Small / Q000503:physiopathology; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism / Q000503:physiopathology; D008286:Malabsorption Syndromes / Q000188:drug therapy / Q000378:metabolism* / Q000628:therapy; D014280:Triglycerides / Q000627:therapeutic use
D001647:Bile Acids and Salts; D004041:Dietary Fats; D005227:Fatty Acids; D014280:Triglycerides; D002792:Cholestyramine Resin